Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cecile Philippe

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Schizophrenia Bulletin|August 13, 2024
Amphetamine-Induced Dopamine Release Predicts 1-Year Outcome in First-Episode Psychosis: A Naturalistic ObservationAna Weidenauer, Ulrich Sauerzopf, Martin Bauer, et al.
Human Brain Mapping|October 26, 2016
Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PETThomas Vanicek, Alexandra Kutzelnigg, Cecile Philippe, et al.
Frontiers in Human Neuroscience|February 22, 2017
Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major DepressionGregory M James, Pia Baldinger-Melich, Cecile Philippe, et al.
Translational Psychiatry|January 22, 2019
Epistasis of HTR1A and BDNF risk genes alters cortical 5-HT1A receptor binding: PET results link genotype to molecular phenotype in depressionAlexander Kautzky, Gregory M James, Cecile Philippe, et al.
Translational Psychiatry|October 6, 2019
Correction: Epistasis of HTR1A and BDNF risk genes alters cortical 5-HT1A receptor binding: PET results link genotype to molecular phenotype in depressionAlexander Kautzky, Gregory M James, Cecile Philippe, et al.
Frontiers in Molecular Neuroscience|July 30, 2019
Serotonin Transporter Binding in the Human Brain After Pharmacological Challenge Measured Using PET and PET/MRLeo R Silberbauer, Gregor Gryglewski, Neydher Berroterán-Infante, et al.
Journal of Affective Disorders|June 23, 2025
Phenotyping extracellular vesicles and their serotonin transporter cargo in major depressive disorderŁukasz Zadka, Benjamin Eggerstorfer, Igor Buzalewicz, et al.
Translational Psychiatry|February 19, 2020
On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D<sub>2/3</sub> receptor agonist radioligand studyAna Weidenauer, Martin Bauer, Ulrich Sauerzopf, et al.
International Journal of Cancer|October 9, 2020
Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancerOsman Aksoy, Jan Pencik, Markus Hartenbach, et al.
Molecular Cancer|August 12, 2023
STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathwayJan Pencik, Cecile Philippe, Michaela Schlederer, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Schizophrenia Bulletin|August 13, 2024
Amphetamine-Induced Dopamine Release Predicts 1-Year Outcome in First-Episode Psychosis: A Naturalistic ObservationAna Weidenauer, Ulrich Sauerzopf, Martin Bauer, et al.
Human Brain Mapping|October 26, 2016
Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PETThomas Vanicek, Alexandra Kutzelnigg, Cecile Philippe, et al.
Frontiers in Human Neuroscience|February 22, 2017
Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major DepressionGregory M James, Pia Baldinger-Melich, Cecile Philippe, et al.
Translational Psychiatry|January 22, 2019
Epistasis of HTR1A and BDNF risk genes alters cortical 5-HT1A receptor binding: PET results link genotype to molecular phenotype in depressionAlexander Kautzky, Gregory M James, Cecile Philippe, et al.
Translational Psychiatry|October 6, 2019
Correction: Epistasis of HTR1A and BDNF risk genes alters cortical 5-HT1A receptor binding: PET results link genotype to molecular phenotype in depressionAlexander Kautzky, Gregory M James, Cecile Philippe, et al.
Frontiers in Molecular Neuroscience|July 30, 2019
Serotonin Transporter Binding in the Human Brain After Pharmacological Challenge Measured Using PET and PET/MRLeo R Silberbauer, Gregor Gryglewski, Neydher Berroterán-Infante, et al.
Journal of Affective Disorders|June 23, 2025
Phenotyping extracellular vesicles and their serotonin transporter cargo in major depressive disorderŁukasz Zadka, Benjamin Eggerstorfer, Igor Buzalewicz, et al.
Translational Psychiatry|February 19, 2020
On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D<sub>2/3</sub> receptor agonist radioligand studyAna Weidenauer, Martin Bauer, Ulrich Sauerzopf, et al.
International Journal of Cancer|October 9, 2020
Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancerOsman Aksoy, Jan Pencik, Markus Hartenbach, et al.
Molecular Cancer|August 12, 2023
STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathwayJan Pencik, Cecile Philippe, Michaela Schlederer, et al.
Pageof 3